Govoptes

HR 2319 · Women and Lung Cancer Research and Preventive Services Act of 2025

Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 380.

Introduced
Mar 25, 2025
Latest action
Apr 22, 2026
Sponsor
Rep. Brendan F. Boyle [D-PA-2]
Policy area
Health
Cosponsors
2

Summary

Women and Lung Cancer Research and Preventive Services Act of 2025 This bill requires the Department of Health and Human Services to conduct an interagency review to accelerate lung cancer research, prevention, and awareness with respect to women and underserved populations. The review must report on the status of existing research and current knowledge gaps; identify new opportunities for collaborative research to determine the causes of lung cancer and advance prevention, screening, diagnosis, and treatment; and provide recommendations for a national lung cancer screening strategy and public education campaign.

Recent actions

  1. Apr 22, 2026 Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 380.
  2. Apr 21, 2026 Motion to reconsider laid on the table Agreed to without objection.
  3. Apr 21, 2026 On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H3020)
  4. Apr 21, 2026 Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H3020)
  5. Apr 21, 2026 DEBATE - The House proceeded with forty minutes of debate on H.R. 2319.
  6. Apr 21, 2026 Considered under suspension of the rules. (consideration: CR H3020-3021)
  7. Apr 21, 2026 Mrs. Harshbarger moved to suspend the rules and pass the bill.
  8. Nov 18, 2025 Placed on the Union Calendar, Calendar No. 332.

Votes

No recorded votes are available for this bill.

Related pages